%0 Journal Article
%T Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database
%A Andrew Hanna
%A Cherif Boutros
%A Max Seaton
%A Nader Hanna
%J Archive of "Therapeutic Advances in Medical Oncology".
%D 2019
%R 10.1177/1758835919842438
%X The optimal multimodality therapy for pancreatic ductal adenocarcinoma in the body or tail of the pancreas (PDAC-BT) is unclear. The purpose of this study was to compare overall 5-year survival between patients treated with adjuvant chemotherapy, adjuvant chemoradiation, and surgery alone
%K adjuvant therapy
%K chemoradiation
%K chemotherapy
%K distal pancreatectomy
%K distal pancreatic cancer
%K National Cancer Database
%K pancreatic body adenocarcinoma
%K pancreatic cancer
%K pancreatic tail adenocarcinoma
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501493/